Related Experiment Video
Updated: Jul 2, 2026

08:33
An Ex vivo Culture System to Study Thyroid Development
Published on: June 6, 2014
Gene expression profiles of post-Chernobyl thyroid cancers
Vincent Detours1, Soetkin Versteyhe, Jacques E Dumont
1IRIBHM, Université Libre de Bruxelles, Brussels, Belgium. vdetours@ulb.ac.be
Current Opinion in Endocrinology, Diabetes, and Obesity
|September 5, 2008
Summary
Radiation exposure can cause cancer, but susceptibility varies. Gene expression may measure this individual risk, impacting cancer research and radioprotection strategies.
Area of Science:
- Genetics
- Oncology
- Radiation Biology
Background:
- Radiation exposure is a known carcinogen.
- Individual susceptibility to radiation-induced cancer varies significantly.
- Previous studies suggest genetic factors may influence cancer development after radiation exposure.
Purpose of the Study:
- To review emerging evidence for a variable, measurable susceptibility to radiation-induced cancer.
- To explore the potential of gene expression as a biomarker for this susceptibility.
- To discuss the implications for cancer research, medicine, and radiation protection.
Main Methods:
- Analysis of gene expression profiles in thyroid cancers (spontaneous and post-Chernobyl).
- Comparison of gene expression in lymphocytes from parents of children with retinoblastoma versus healthy children.
- Examination of familial clustering patterns in radiation-induced meningiomas.
Main Results:
- Gene expression 'radiation signatures' identified in thyroid cancers, potentially linked to tumor origin and DNA repair.
- Distinct gene expression patterns found in lymphocytes of parents with a history of childhood retinoblastoma, correlating with increased radiosensitivity.
- Familial aggregation observed in radiation-induced meningiomas, suggesting a hereditary component.
Conclusions:
- A variable susceptibility to radiation-induced cancer exists, explaining why only a subset of highly exposed individuals develop cancer.
- Gene expression analysis offers a potential method to quantify individual cancer susceptibility.
- Measuring this susceptibility has significant implications for personalized medicine, risk assessment, and radioprotection.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...